NervGen Pharma Corp. Common stock

$4.04
-0.03 (-0.74%)

Volume:

85.249K ($344.43K)

Market Capitalization:

$325.38M

NervGen Pharma Corp. Common stock Price Chart

NervGen Pharma Corp. Common stock Price Chart5:50 AM7:10 AM8:30 AM9:50 AM11:10 AM12:30 PM1:50 PM4.184.154.124.094.074.044.01

NervGen Pharma Corp. Common stock Volume Chart

NervGen Pharma Corp. Common stock Volume Chart5:50 AM7:10 AM8:30 AM9:50 AM11:10 AM12:30 PM1:50 PM20.31K17.41K14.51K11.61K8.71K5.80K2.90K

NervGen Pharma Corp. Common stock Market Segments

Regular Trading Hours

-0.10(-2.42%)
Open$4.14
Close$4.04
Low$4.01
Low Change-0.13 (-3.14%)
High$4.15
High Change+0.01 (+0.24%)
Range$0.14
Volume85.074K
Dollar Volume$343.70K

Premarket

+0.00(+0.00%)
Open$4.18
Close$4.18
Low$4.18
Low Change0.00 (0.00%)
High$4.18
High Change+0.00 (+0.00%)
Range$0.00
Volume175
Dollar Volume$731.31

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.17(-4.01%)
Open$4.24
Close$4.07
Low$4.06
Low Change-0.18 (-4.25%)
High$4.25
High Change+0.01 (+0.24%)
Range$0.19
Volume100.599K
Dollar Volume$409.44K

Premarket Yesterday

+0.00(+0.00%)
Open$4.29
Close$4.29
Low$4.29
Low Change0.00 (0.00%)
High$4.29
High Change+0.00 (+0.00%)
Range$0.00
Volume372
Dollar Volume$1.60K

NervGen Pharma Corp. Common stock Moving Averages

5 Day Moving Average (SMA5)$4.16
10 Day Moving Average (SMA10)$4.16
20 Day Moving Average (SMA20)$4.04
50 Day Moving Average (SMA50)$4.05
100 Day Moving Average (SMA100)
200 Day Moving Average (SMA200)

NervGen Pharma Corp. Common stock Statistics

Average Volume (30 Days)
P/E Ratio (Current)
EPS (Current)
Dividend Yield
Free Cash Flow
Cash Ratio
Current Ratio
Quick Ratio
Debt to Equity
Enterprise Value
EV to EBITDA
EV to Sales
Price to Book
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets
Return on Equity

NervGen Pharma Corp. Common stock Stock Splits

There have been no stock splits for NervGen Pharma Corp. Common stock (NGEN).

NervGen Pharma Corp. Common stock Dividends

There have been no dividends for NervGen Pharma Corp. Common stock (NGEN).